Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to buy: Sagar Doshi suggests Varun Beverages, Max Healthcare, Page Industries shares to buy
The Indian stock market saw a marginal rise amid optimism over a potential nuclear deal with Iran. Nifty 50 advanced 0.11%, and the BSE Sensex increased by 0.17%. Despite this, Bank Nifty fell nearly 200 points, while analysts suggested specific stocks to buy.
Q4 Results LIVE Updates: IOC, Astral, Afcons react to earnings; BPCL, BEL report today
Q4 Results LIVE Updates: BPCL, Zydus Life, BEL, BLS International, Dhanuka Agri, Dredging Corp, Eureka Forbes, Hatsun Agro, Healthcare Global, J Kumar Infra, PI Industries, PNC Infratech, Prince Pipes, Safari Industries, RITES, Trident, Zee Entertainment, Shaily Engineering are among the other important numbers to track today along with result reactions from IOC, IGL, Afcons, Astral and many others. Stay tuned for all the live result reactions right here.
Pharmacy associations to skip strike, major medicine disruption unlikely
India's drug regulator is actively reviewing concerns from retail chemists about e-pharmacies. The All India Organisation of Chemists and Druggists had called for a strike. However, many pharmacy associations have stepped back, citing public interest and patient access. The regulator assures that issues are under consideration. Dialogue is seen as key to ensuring uninterrupted healthcare services for citizens.
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA Healthcare - Investing.com India
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA HealthcareInvesting.com India
GPT Healthcare Q4 PAT rises 13% YoY to Rs 15 crore
GPT Healthcare reported a 13.03% rise in consolidated net profit to Rs 14.57 crore in Q4 FY26, compared with Rs 12.89 crore in Q4 FY25.
Healthcare stock Cupid shows resilience against the stock market sell-off
Cupid share price rose 3.4% on May 18 after announcing strong Q4 FY26 results, with a 26% year-over-year income increase. The company plans aggressive growth, targeting ₹600 crore revenue in FY27 and expanding its FMCG distribution and product portfolio.
Meta May 20 layoff: As ‘doomsday’ nears, anxious employees stock up on free snacks, charges; apply preemptively
Employees have described the severance package as unexpectedly generous, calling it a “golden parachute” as the tech firm tries to soften the blow with 18 months of healthcare coverage.
Upcoming dividends, stock splits, buybacks this week: L&T, Havells India, ITC Hotels, Metropolis Healthcare, GM Breweries among others in focus - Upstox
Upcoming dividends, stock splits, buybacks this week: L&T, Havells India, ITC Hotels, Metropolis Healthcare, GM Breweries among others in focusUpstox
Athena opens northeast India’s largest integrated psychiatric hospital in Guwahati
Athena Behavioral Health opens Northeast India's largest private psychiatric hospital in Guwahati. This marks their fifth hospital nationwide. The facility offers integrated treatment for mental health and substance use disorders. It aims to address the region's growing needs and shortage of structured care. The launch signifies a crucial step in making quality mental healthcare accessible in underserved areas.
Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answer
The gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath bridges this gap by shifting the focus from simple automation to end-to-end orchestration
Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).
Max Healthcare sets board meeting date to declare Q4 results 2026, final dividend for FY26
Max Healthcare Institute's Board of Directors will meet on May 21, 2026, to review financial results for the quarter and year ended March 31, 2026, and discuss a potential final dividend. The trading window for securities will remain closed until 48 hours after results are declared.